Endogenous lipoid pneumonia associated with Legionella pneumophila serogroup 1.
- Author:
Chee-Kin HUI
1
Author Information
1. Quality Healthcare Medical Service, 6/F HK Pacific Centre, 28 Hankow Road, Tsim Sha Tsui, Kowloon, Hong Kong SAR, China. bckhui@gmail.com.
- Publication Type:Case Reports
- MeSH:
Adult;
Anti-Bacterial Agents;
therapeutic use;
Aza Compounds;
therapeutic use;
Azithromycin;
therapeutic use;
Female;
Fluoroquinolones;
Humans;
Legionella pneumophila;
classification;
Legionnaires' Disease;
diagnosis;
drug therapy;
microbiology;
Pneumonia, Lipid;
diagnosis;
drug therapy;
microbiology;
Quinolines;
therapeutic use;
Treatment Outcome
- From:Singapore medical journal
2013;54(3):e66-7
- CountrySingapore
- Language:English
-
Abstract:
Endogenous lipoid pneumonia is an uncommon condition. This is a report of a 29-year-old woman diagnosed with endogenous lipoid pneumonia associated with Legionella pneumophila serogroup 1 infection. The patient's endogenous lipoid pneumonia resolved completely after treatment for Legionella pneumophila infection. This suggests that early diagnosis and aggressive treatment of the underlying infection may prevent any long-term sequelae of lipoid pneumonia.
